Vetter joins United Nations Global Compact Network
Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network.
They join 308 other biopharmaceutical companies who are also a part of the agreement to work towards more sustainable business practices. Outside of the biopharmaceutical field, over 15,000 companies and 3,000 not-for-profit organisations, from 160 countries, are included in the network.
The Network is defined by ten principles, which Vetter will now have to follow as part of it’s corporate actions. The main focus of the principles is upholding human and employee rights, engaging tactics to prevent corruption, and to limit global warming.
Henryk Badack, Senior Vice President Technical Service and Internal Project Management at Vetter explained:
"We have already been pursuing a very ambitious sustainability strategy for years. By committing to the goals of the UN Global Compact, we are reaching the next level and are further expanding our initiatives to a global level."
As a collaborative network, Vetter will be able to join forces with the other companies within the agreement to work towards the same goals. The initiative means that these companies and organisations can share knowledge, ideas, and resources in the hope of upgrading processes and inciting change across the industry. Vetter will be held accountable to the goals of the compact network through a written annual report that will be open to the public, which doubles as evidence of the project and a progress report to inform the wider network.
"As a family-owned business in the healthcare sector, we bear great responsibility,” stated Badack. “And we believe in the power of cooperation. The UN Global Compact combines these two approaches very well and is also a strong commitment to shared values and goals across business sectors and national borders."
Vetter had already in place a set of it’s own sustainability values and targets, the combination will serve to better support their customers in ensuring a more sustainable supply chain and more ESG-friendly operations.
Join a global discussion at CPHI Barcelona
What does the UN Global Compact Network mean for your business – and the wider pharma industry? Join us at CPHI Barcelona and hear from expert speakers about the many, varied ways we can all work towards more sustainable practices.
Your CPHI Barcelona pass gives you access to all conference sessions, including the Creating a Circular Economy conference track, as well as the chance to connect in-person with the global pharma supply chain from 24-26 October, at Fira Barcelona Gran Via. Browse the agenda and secure your pass today!
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance